Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology

The coronavirus disease 19 (COVID-19) pandemic has become the focus of attention worldwide, and herein we seek to highlight the potential problem of ‘collateral mortality’ from delayed or deferred treatments in patients with cancer. We propose potential solutions to ensure continuity of care in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ker-Kan, Moran, Brendan J., Solomon, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199649/
https://www.ncbi.nlm.nih.gov/pubmed/32372035
http://dx.doi.org/10.1038/s41571-020-0383-1
Descripción
Sumario:The coronavirus disease 19 (COVID-19) pandemic has become the focus of attention worldwide, and herein we seek to highlight the potential problem of ‘collateral mortality’ from delayed or deferred treatments in patients with cancer. We propose potential solutions to ensure continuity of care in the field of surgical oncology.

Ejemplares similares